HANNAH KAUFFELD: Open Payments
NPI 1992474977 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 78 payments from 16 companies in 2025. Trend: 2023 $1,513 · 2024 $1,253 · 2025 $1,138
Food & beverage: $1,019Education: $119
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $288 |
| Janssen Biotech, Inc. | 11 | $205 |
| Ardelyx, Inc. | 15 | $162 |
| Phathom Pharmaceuticals, Inc. | 8 | $110 |
| GENZYME CORPORATION | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Madrigal Pharmaceuticals | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Aimmune Therapeutics, Inc. | 2 | $30 |
| Lilly USA, LLC | 2 | $27 |
Products named: TREMFYA, RINVOQ, IBSRELA, VOQUEZNA, DUPIXENT, CREON, XIFAXAN, REZDIFFRA.
Industry payments across KY — which companies pay providers there.
